相关实验视频

Updated: Jan 15, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

治疗相关的骨髓瘤,相同但不同?

Lina El Murr¹, Khalil Saleh², Florence Pasquier³

¹Hematology Department, Institut Gustave-Roussy, Villejuif (Île-de-France), France.

Bulletin du cancer

|October 9, 2025

概括

与治疗相关的骨髓瘤 (t-MNs) 的生存时间有限,对于t-AML和t-MDS,平均总生存时间为11.9个月. 强化疗法可能有利于选定的患者,但不良预后因素显著影响结果.

科学领域:

血液学血液学血液学
在瘤学瘤学.
癌症研究癌症研究

背景情况:

与治疗相关的骨髓瘤 (t-MNs) 是癌症治疗后的严重并发症.
这些包括与治疗相关的急性髓性白血病 (t-AML) 和与治疗相关的骨髓分裂综合征 (t-MDS).

研究的目的:

分析大量t-MNs患者队列中的预后因素和生存结果.
评估不同风险分类对患者存活率的影响.

主要方法:

从1995年至2018年,对404名患有t-MNs的患者 (204名t-AML,200名t-MDS) 进行了回顾性研究.
使用2010年欧洲白血病网 (ELN) 对t-AML的分类以及对t-MDS的国际预后评分系统 (IPSS).
进行多变量分析以确定总生存期 (OS) 的独立预后标志物.

主要成果:

对于t-AML和t-MDS,中位数的生存期为11.9个月.
与t-MDS相比,t-AML (5年生存率24.6%) 的长期存活率更高 (5年生存率10.6%).
对于t-AML,密集治疗,不良ELN风险,癌症疾病状态和不良表现状态是显著的OS预测因素.
对于t-MDS,高IPSS得分和低绩效状态是独立的OS标记.

结论:

对于t-MNs的存活率仍然有限,特别是在不良预后特征或活跃恶性瘤的情况下.
强化疗法在特定的t-MN病例中显示出一些益处.
预后分类如ELN和IPSS对于t-MN患者的风险分层至关重要.

关键词:

急性骨髓性白血病 (AML) 是一种急性骨髓性白血病.骨髓分裂性综合征骨髓分裂性综合征在PPM1D中,它是PPM1D.这就是TP53的特点.与治疗相关的骨髓状瘤.

更多相关视频

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Published on: October 3, 2018

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies

Published on: November 10, 2023

相关概念视频

Differentiation of Common Myeloid Progenitor Cells

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...

Bone Marrow Sampling and Transplants

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...